These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1084127)

  • 1. Immunoglobulin binding factor (IBF) produced by T cells: selective interaction with slow migrating rabbit IgC.
    Guimezanes A; Fridman WH; Kourilsky FM
    Ann Immunol (Paris); 1975; 126(5-6):541-51. PubMed ID: 1084127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.
    Schreiber AD; Frank MM
    J Clin Invest; 1972 Mar; 51(3):583-9. PubMed ID: 4622104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible binding of a T cell factor on IgG-coated sepharose beads.
    Guimezanes A; Fridman WH; Gisler RH; Kourilsky FM
    Eur J Immunol; 1976 Jan; 6(1):69-72. PubMed ID: 971721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of suppressive immunoglobulin-binding factor (IBF). I. Production of IBF by a theta-positive lymphoma (L-5178-Y).
    Fridman WH; Guimezanes A; Gisler RH
    J Immunol; 1977 Oct; 119(4):1266-8. PubMed ID: 302279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of an immunoglobulin-binding factor (IBF) by antigen-stimulated lymph node lymphocytes.
    Fridman WH; Nelson RA; Liabeuf A
    J Immunol; 1974 Sep; 113(3):1008-16. PubMed ID: 4137896
    [No Abstract]   [Full Text] [Related]  

  • 6. Lysis of hapten-labeled cells by anti-hapten IgG and complement: effect of cell surface hapten density.
    Circolo A; Borsos T
    J Immunol; 1982 Mar; 128(3):1118-21. PubMed ID: 7057033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of suppressive immunoglobulin-binding factor (IBF). III. Biochemical and immunochemical characteristics of IBF produced by activated T cells.
    Joskowicz M; Rabourdin-Combe C; Neauport-Sautes C; Fridman WH
    J Immunol; 1978 Aug; 121(2):777-83. PubMed ID: 79616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptors for IgG and complement in human spleen lymphoid cells. Preferential binding of particulate immune complexes through complement receptors.
    Scornik JC; Drewinko B
    J Immunol; 1975 Nov; 115(5):1223-6. PubMed ID: 1176774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of antigen-specific T cell factors with unique "receptors" on the surface of mast cells: demonstration in vitro by an indirect rosetting technique.
    Kops SK; Ratzlaff RE; Meade R; Iverson GM; Askenase PW
    J Immunol; 1986 Jun; 136(12):4515-24. PubMed ID: 2423595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of immunoglobulin to complement receptors of human B cells.
    Abrahamsohn I; Nilsson UR; Abdou NI
    J Immunol; 1974 May; 112(5):1931-8. PubMed ID: 4594420
    [No Abstract]   [Full Text] [Related]  

  • 11. [Proceedings: Preparation and dosage of IBF produced by T cells. Effect on antibody production in vitro].
    Guimezanes A; Fridman WH; Gisler R; Kourilsky FM
    Ann Immunol (Paris); 1975 Apr; 126(3):357. PubMed ID: 1080987
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibody-dependent cell-mediated cytotoxicity. I. Differentiation from antibody-independent cytotoxicity by "normal" IgG.
    Scornik JC; Cosenza H; Lee W; Köhler H; Rowley DA
    J Immunol; 1974 Nov; 113(5):1510-8. PubMed ID: 4153633
    [No Abstract]   [Full Text] [Related]  

  • 13. The lymphocytotoxic reaction: the mechanism of rabbit complement action.
    Ferrone S; Cooper NR; Pellegrino MA; Reisfeld RA
    J Immunol; 1971 Oct; 107(4):939-47. PubMed ID: 4999260
    [No Abstract]   [Full Text] [Related]  

  • 14. Idiotypic determinants on human T cells and modulation of human T cell responses by anti-idiotypic antibodies.
    Geha RS
    J Immunol; 1984 Oct; 133(4):1846-51. PubMed ID: 6206140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement dependent hemolysis of sheep erythrocytes coupled with non-antibody human IgG.
    Inai S; Tsuyuguchi I
    Biken J; 1968 Dec; 11(4):261-7. PubMed ID: 4181155
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of suppressive immunoglobulin-binding factor (IBF). II. Purification and molecular weight determination of IBF produced by L-5178-Y theta-positive lymphoma.
    Neauport-Sautes C; Fridman WH
    J Immunol; 1977 Oct; 119(4):1269-74. PubMed ID: 330762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of in vitro antibody synthesis by immunoglobulin-binding factor.
    Gisler RH; Fridman WH
    J Exp Med; 1975 Aug; 142(2):507-17. PubMed ID: 1079850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that rabbit gamma G haemolysin in capable of utilizing guinea-pig complement more efficiently than rabbit gamma M haemolysin.
    Frank MM; Gaither T
    Immunology; 1970 Dec; 19(6):975-81. PubMed ID: 5487544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement: a reversible temperature-dependent alteration in the reactivity of EAC1 with C4.
    Linscott WD
    J Immunol; 1973 Jul; 111(1):200-11. PubMed ID: 4197334
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of PCA reactive and hemolytic rabbit antibodies to sheep red blood cells.
    Warner NL; Ovary Z
    J Immunol; 1970 Jun; 104(6):1429-34. PubMed ID: 5419279
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.